ArticleJournal of community hospital internal medicine perspectives2025
Subcutaneous Insulin Aspart Every 4 Hours in the Treatment of COVID-19 Patients With Mild-to-Moderate Diabetic Ketoacidosis: A Case Series.
Dararat Chiewchalermsri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.